| Clare Marie Herubin, DPT | |
|
21 Fleetwood Ave, Albany, NY 12208-2307 | |
| (518) 817-5095 | |
| Not Available |
| Full Name | Clare Marie Herubin |
|---|---|
| Gender | Female |
| Speciality | Physical Therapist |
| Location | 21 Fleetwood Ave, Albany, New York |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1801408885 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | (* (Not Available)) | Primary |
| Provider Name | Fox Rehabilitation Physical Therapy Services Llc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1174560650 PECOS PAC ID: 1355395179 Enrollment ID: O20061023000060 |
News Archive
Sonomax Hearing Healthcare Inc. announces that with reference to its previously-announced conference call scheduled for February 4th, 2010 at 11:00 AM EST, in addition to updating investors on the results of Sonomax's initiative to license its new Self-Fit(TM) headset technology at the recent Consumer Electronics Show in Las Vegas, and the company's outlook for 2010 and beyond, the company will also report on the $1.74 million non-dilutive financing arrangement that it has entered into with Benvest New Look Income Fund.
Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.
Researchers hope to discover why some people struggle with their spirituality or religious beliefs and practices in the face of life's challenges while others don't.
Researchers at The Wistar Institute announce the release of an online tool that will help scientists find "gene promoters"—regions along a DNA strand that tell a cell's transcription machinery where to start reading in order to create a particular protein.
The College of American Pathologists today announced new recommendations for strengthening oversight of laboratory-developed tests (LDTs), proposing a three-tier 'risk-based' system that would protect patients by ensuring every laboratory developed test is reported to an oversight body, and instituting a graduated system of review based on a test's potential risk to patients.
› Verified 6 days ago
| Provider Name | Thrive Physical Therapy Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1215494604 PECOS PAC ID: 7719229285 Enrollment ID: O20190502001266 |
News Archive
Sonomax Hearing Healthcare Inc. announces that with reference to its previously-announced conference call scheduled for February 4th, 2010 at 11:00 AM EST, in addition to updating investors on the results of Sonomax's initiative to license its new Self-Fit(TM) headset technology at the recent Consumer Electronics Show in Las Vegas, and the company's outlook for 2010 and beyond, the company will also report on the $1.74 million non-dilutive financing arrangement that it has entered into with Benvest New Look Income Fund.
Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.
Researchers hope to discover why some people struggle with their spirituality or religious beliefs and practices in the face of life's challenges while others don't.
Researchers at The Wistar Institute announce the release of an online tool that will help scientists find "gene promoters"—regions along a DNA strand that tell a cell's transcription machinery where to start reading in order to create a particular protein.
The College of American Pathologists today announced new recommendations for strengthening oversight of laboratory-developed tests (LDTs), proposing a three-tier 'risk-based' system that would protect patients by ensuring every laboratory developed test is reported to an oversight body, and instituting a graduated system of review based on a test's potential risk to patients.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Clare Marie Herubin, DPT 21 Fleetwood Ave, Albany, NY 12208-2307 Ph: (518) 817-5095 | Clare Marie Herubin, DPT 21 Fleetwood Ave, Albany, NY 12208-2307 Ph: (518) 817-5095 |
News Archive
Sonomax Hearing Healthcare Inc. announces that with reference to its previously-announced conference call scheduled for February 4th, 2010 at 11:00 AM EST, in addition to updating investors on the results of Sonomax's initiative to license its new Self-Fit(TM) headset technology at the recent Consumer Electronics Show in Las Vegas, and the company's outlook for 2010 and beyond, the company will also report on the $1.74 million non-dilutive financing arrangement that it has entered into with Benvest New Look Income Fund.
Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.
Researchers hope to discover why some people struggle with their spirituality or religious beliefs and practices in the face of life's challenges while others don't.
Researchers at The Wistar Institute announce the release of an online tool that will help scientists find "gene promoters"—regions along a DNA strand that tell a cell's transcription machinery where to start reading in order to create a particular protein.
The College of American Pathologists today announced new recommendations for strengthening oversight of laboratory-developed tests (LDTs), proposing a three-tier 'risk-based' system that would protect patients by ensuring every laboratory developed test is reported to an oversight body, and instituting a graduated system of review based on a test's potential risk to patients.
› Verified 6 days ago
Jordan Iris Bakowski, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 900 Watervliet Shaker Rd, Suite 102, Albany, NY 12205 Phone: 518-862-4900 | |
Yuan Kenneth Jin, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 121 Everett Rd Ste 200, Albany, NY 12205 Phone: 518-489-2524 Fax: 518-489-3167 | |
Penelope M Blasch, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-453-2273 | |
Heather M. Lacasse, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 121 Everett Rd Health Park, Albany, NY 12205 Phone: 518-489-2524 Fax: 518-489-3167 | |
Marianna Vaysman, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 281 Sand Creek Rd, Albany, NY 12205 Phone: 518-459-1292 Fax: 518-459-1296 | |
Kimberly Silvernail Keane, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-453-2273 | |
Dr. Janel Lena Carver, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 80 Clinton Ave Apt 1, Albany, NY 12210 Phone: 914-299-9514 |